Molecular Cancer Therapeutics publishes articles on the discovery and preclinical development of novel therapeutic agents for oncology, preclinical studies of approved therapeutics, mechanisms of drug ...

The genetics and biology of pediatric cancer are distinct from those of adult cancer. A growing number of predictive, diagnostic, therapeutic and prognostic biomarkers have been identified at a ...

Therapeutic touch is based on the belief that the subtle manipulation of the body’s energetic biofield can promote well-being and healing. Research suggests that it may offer some benefits, but ...

On Thursday, Pasithea Therapeutics Corp. (NASDAQ:KTTA) announced safety, tolerability, pharmacokinetic (PK), and preliminary efficacy data from the first 2 cohorts of patients (n=6) in its Phase 1 ...

Viking Therapeutics, Inc. stock has surged nearly 1,500% since 2023, driven by the promising GLP-1/GIP receptor agonist VK-2735 for obesity. VK-2735's Phase 2 data showed weight loss comparable to ...

The CRISPR–Cas13 system has wide clinical applications, such as diagnostics for RNA viruses, RNA imaging, RNA-base editing, RNA epigenome editing, and therapeutic interventions.

for oral presentation. The presentation will be given by Circio´s CTO, Dr. Thomas B Hansen on 23 October 2024. "Circio´s unique and powerful circVec platform keeps building momentum, and we ...

Capricor Therapeutics announces intent to file a biologics license application for the full approval of Deramiocel. Capricor plans to commence the filling in October, with full submission expected ...

In addition new therapeutic targets are being discovered ... Currently, there are studies utilizing RNA interference technology to target degradation of oncogenic circRNAs and to develop circRNA-based ...

Summit Therapeutics' ivonescimab shows improved efficacy over Merck's Keytruda in Phase III trials, targeting both PD-1 and VEGF, potentially expanding the PD-1 inhibitor market. Despite risks ...